Your browser doesn't support javascript.
loading
Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables in Patients with Hypertrophic Cardiomyopathy.
Maron, Martin S; Chan, Raymond H; Kapur, Navin K; Jaffe, Iris Z; McGraw, Adam P; Kerur, Raj; Maron, Barry J; Udelson, James E.
Afiliação
  • Maron MS; Hypertrophic Cardiomyopathy Institute, Division of Cardiology, Tufts Medical Center, Boston, Mass. Electronic address: mmaron@tuftsmedicalcenter.org.
  • Chan RH; Division of Cardiology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Kapur NK; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Mass.
  • Jaffe IZ; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Mass.
  • McGraw AP; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Mass.
  • Kerur R; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Mass.
  • Maron BJ; Hypertrophic Cardiomyopathy Institute, Division of Cardiology, Tufts Medical Center, Boston, Mass.
  • Udelson JE; Hypertrophic Cardiomyopathy Institute, Division of Cardiology, Tufts Medical Center, Boston, Mass.
Am J Med ; 131(7): 837-841, 2018 07.
Article em En | MEDLINE | ID: mdl-29604289

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espironolactona / Cardiomiopatia Hipertrófica / Antagonistas de Receptores de Mineralocorticoides / Miocárdio Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male Idioma: En Revista: Am J Med Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espironolactona / Cardiomiopatia Hipertrófica / Antagonistas de Receptores de Mineralocorticoides / Miocárdio Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male Idioma: En Revista: Am J Med Ano de publicação: 2018 Tipo de documento: Article